Zubair W. Baloch, MD, PhD

Pathology and Laboratory Medicine
Accepting new patients
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
Headshot of Zubair W. Baloch, MD, PhD
Penn Medicine Provider

About me

  • Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

My education and training

  • Medical School: Liaquat Medical College
  • Residency: Hahnemann University Hospital
  • Fellowship: Memorial Sloan-Kettering Cancer Center
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English
اردو
Urdu
Sindhi
Sindhi

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Baloch is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Layfield LJ, Cantley RL, Dodd L, Pantanowitz L, Baloch Z, Esebua M, Maleki Z, Ge B. Cytomorphologic Predictors of Adenoid Cystic Carcinoma: Insights From a Multi-Center Logistic Regression Study , Diagn Cytopathol, 54(7): 2026,463-468


Torous VF, Heidarian A, Baloch ZW, Maleki Z, Montone K, Rossi ED, Faquin WC. Evaluating the role of metaplasia in the cytologic diagnosis of pleomorphic adenoma: A multi-institutional study of 253 cases , Cancer Cytopathol, 134(6): 2026


Canberk S, Azevedo MT, Cozzolino I, Arisi MF, Mericoz ÇA, Aydin O, Baloch ZW, Bellevicine C, Bongiovanni M, Firat P, Ince U, Kayhan CK, Kurtulan O, Liang S, Maleki Z, Magalhães BM, Vrdoljak-Mozetic D, Onder S, Ramqvist E, Raymond WA, Troncone G, Uguz A, Vale N, Vigliar E, Field AS, Schmitt FC, VanderLaan P. WHOverlap Multicentre Study: Dissecting the Insufficient/Inadequate/Non-Diagnostic Category and Its Overlap with the Benign Category in the WHO Reporting System for Lung Cytopathology , Acta Cytol, 70(2): 2026,160-174


Jin, Xueting, Koga, Shunsuke, Zhou, Xiao, Khan, Niaz, Baloch, Zubair Clinicopathologic characteristics of papillary thyroid carcinoma, tall cell subtype and subtype with tall cell features, an institutional experience (accepted for publication). , Hum Pathol, 161: 2025


Xu B, Viswanathan K, Barbesier M, Ladenheim A, Antonescu CR, Ghossein R, Lubin D, Magliocca K, Matar S, Mikula MW, Resta IT, Roy D, Sohn SY, Verma A, Prasad ML, Rooper L, Brandwein-Weber M, Baloch Z, Katabi N. Hyalinizing Clear Cell Carcinoma (HCCC) of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading scheme , Mod Pathol: 2025


Hu AC, Passman JE, Baloch Z, Wachtel H. Adrenalectomy Leading to Early Diagnosis of ALECT2 Amyloidosis , Sage Open Pathol, 18: 2025,30502098251331780


Nachum S, Tondi Resta I, Baloch Z, Mandel SJ. Thyroid Nodules with Indeterminate Cytology and Negative Molecular Profile: Prevalence of Malignancy and Practice Paradigms for Surveillance , Thyroid, 35(3): 2025,265-273


Rossi ED, Agarwal S, Erkilic S, Hang JF, Jalaly JB, Khanafshar E, Ladenheim A, Baloch Z. Psammoma bodies in thyroid: are they always indicative of malignancy? A multi-institutional study , Virchows Arch, 485(5): 2024,853-858


Baran J, Bojarsky M, Halada S, Ricarte-Filho JC, Isaza A, Franco AT, Surrey LF, Bhatti T, Baloch ZW, Adzick NS, Mostoufi-Moab S, Kazahaya K, Bauer A. Low-Invasive Somatic Oncogenes and Lymph Node Metastasis in Pediatric Papillary Thyroid Cancer: Implications for Prophylactic Central Neck Dissection , Eur Thyroid J, 13: 2024,e230265


Arisi MF, Jin X, Ravish NA, Chand MT, Baloch Z. How important are the cytomorphologic subtypes of the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan system for reporting salivary gland cytology? An institutional experience 2018-2024 , Diagn Cytopathol: 2024


View all publications